Where to Inject Tirzepatide: Best Site for Weight Loss + Pain Reduction

TL;DR — 3 sites, simple rotation

Tirzepatide (Zepbound for weight loss, Mounjaro for type 2 diabetes) is injected subcutaneously — into the fat layer just under the skin. The FDA label approves three injection sites:

• Abdomen — avoid the 2-inch radius around your navel
• Front of the thigh — midway between hip and knee
• Back of the upper arm — FDA label notes this site should be administered by another person for self-injection

Rotation rule: Do not inject into the same exact spot in the same week. Rotate at least 1 inch (about 2.5 cm) from your previous injection point. Avoid skin that is bruised, red, tender, scarred, or hard.

Most practical for solo self-injection: abdomen or thigh. Warm the pen to room temperature for 30 minutes before injecting — cold injections hurt more.

The 3 FDA-approved injection sites

The Zepbound prescribing information (Section 2, Dosage and Administration) states verbatim:

“Inject subcutaneously in the abdomen, thigh, or upper arm.” ^[1]

The Mounjaro prescribing information (same molecule, type 2 diabetes indication) contains substantively identical language for the same three sites. ^[2] Both are manufactured by Eli Lilly; the injection-technique instructions do not differ between the two labels.

Abdomen

The abdomen is the most commonly used site. It has a consistent subcutaneous fat layer in most patients, is easily accessible for self-injection without contortion, and allows direct visual confirmation of the injection.

• Where exactly: Anywhere on the soft tissue of the lower or lateral abdomen — but avoid a roughly 2-inch (5 cm) radius around the navel (belly button). The tissue directly around the navel has a thinner fat layer and more blood vessels close to the surface.
• Left vs right: Both sides are fine. Alternating left and right helps with site rotation.
• Waistband caution: Avoid injecting into the waistband crease or where clothing elastic presses — repeated pressure on an injection site can delay healing.

Front of the thigh

The thigh is the second most used site and is often preferred by patients who find the abdomen awkward. It is clearly visible during injection and easy to stabilize.

• Where exactly: The front (anterior) or outer side (lateral) of the thigh, roughly in the middle third between the hip and the knee. Avoid the inner thigh (more sensitive, more blood vessels) and the area behind the knee.
• Seated position: Sit with the thigh flat and relaxed before injecting — a tense muscle can cause pain and increase the risk of hitting muscle instead of subcutaneous fat.

Back of the upper arm

The upper arm is an approved site but comes with a practical caveat directly from the FDA label. The Zepbound prescribing information states that upper-arm injection “should be given by another person” ^[1] — meaning self-injection at this site is not recommended.

• Where exactly: The back (posterior) surface of the upper arm, midway between the shoulder and elbow, in the triceps region.
• Why it requires assistance: Reaching the back of your own upper arm with a pen auto-injector while stabilizing the skin, ensuring perpendicular contact, and completing the injection is genuinely difficult without a second person. Attempting it alone increases the risk of an angled injection that misses the subcutaneous layer.
• When it is useful: Patients who have a caregiver, nurse, or partner who administers the injection, or patients whose abdomen and thighs are not suitable injection sites due to scarring or lipohypertrophy.

Best site for absorption, pain, and convenience

On absorption: Subcutaneous pharmacokinetics studies for GLP-1 receptor agonists consistently show that abdominal injection produces the fastest peak plasma concentration, primarily because abdominal subcutaneous tissue has a denser capillary network than the thigh or arm. For a once-weekly drug like tirzepatide, this difference in absorption rate is clinically minor — the drug accumulates to steady state over 4–5 weeks regardless of site. The weight-loss effect of tirzepatide does not depend on picking one site over another.

On pain: Cold medication is the most common cause of injection pain. Let the pen or vial sit at room temperature for 30 minutes before every injection. Beyond temperature, the thigh and abdomen have roughly equivalent pain profiles for most patients. If one site consistently hurts more, switch to the other for a few weeks and see if there is lipohypertrophy at the painful site (see Section 4).

Bottom line: For most patients doing solo weekly self-injection, the abdomen is the best all-around site. The thigh is equally good and preferred by many patients who find the abdomen uncomfortable. Rotate between both. Reserve the upper arm for when a second person is available.

How to rotate sites (avoid lipohypertrophy)

Lipohypertrophy is a thickened, lumpy area of subcutaneous fat that develops when the same injection spot is used too frequently. It looks like a raised bump or feels firmer than surrounding tissue. Injecting repeatedly into a lipohypertrophied area is a problem because:

• Drug absorption from that area becomes slower and less predictable
• The tissue continues to accumulate damage, making the problem worse
• It can mask early signs of infection or a more serious reaction

The Zepbound label states verbatim:

“Avoid injecting ZEPBOUND into the same injection site within the same week. Do not inject ZEPBOUND into areas where the skin is tender, bruised, red, scaly, or hard. Avoid injecting into areas with scars or stretch marks.” ^[1]

Practical rotation system for weekly tirzepatide:

1. Map each site into zones. Think of your abdomen as a clock face around the navel. You have roughly 8–10 distinct injection zones at the 2, 4, 6, 8, and 10 o’clock positions on each side. Similarly, divide each thigh into upper-third, middle, and lower-third lateral zones.
2. Move at least 1 inch between consecutive injections. Each new injection point should be at least 1 inch (~2.5 cm) from the previous point at that site. Over time this creates a large enough rotation that any single spot only gets used every 2–3 months.
3. Rotate between sites, not just within one. If you only use the abdomen, you will exhaust the available zones faster. Alternating between abdomen and thigh doubles your rotation space.
4. Check before every injection. Before you inject, look at the area and feel it gently. Avoid any spot that is bruised, red, raised, or feels harder than the surrounding tissue.
5. Track your injections. A simple weekly journal (pen and paper, phone note, or a GLP-1 tracking app) of which side and zone you used makes rotation effortless.

Step-by-step injection technique

These steps apply to the Zepbound single-dose auto-injector pen. Compounded tirzepatide from a licensed pharmacy is typically supplied as a multi-dose vial with syringes — the site-selection and rotation rules are identical, but the syringe technique differs (see Section 8).

Before you inject

1. Remove from refrigerator 30 minutes early. Injecting cold tirzepatide is the single most common cause of stinging pain. Set a timer. Do not try to warm the pen in hot water or a microwave — heat damages the drug. Room temperature (up to 86°F / 30°C) for up to 21 days is acceptable per the Zepbound label.^[1]
2. Inspect the pen. Through the viewing window, the solution should be clear to slightly yellow, with no particles. Do not use if cloudy, discolored, or if the gray plunger is already showing.
3. Clean the injection site. Wipe with an alcohol swab and let the area dry completely before injecting — wet alcohol at the injection site increases stinging.
4. Remove the cap. Pull off the base cap of the pen (the side you press against skin). Do not push the injection button until the pen is against your skin.

Injecting

1. Do not pinch the skin. The Zepbound label states verbatim: “Do not pinch the skin.” ^[1] Pinching can introduce the needle at an angle or cause the needle to miss the subcutaneous fat layer. Hold the pen flat and perpendicular to the skin surface.
2. Press the pen firmly against skin. Hold it at 90 degrees to the injection site. The pen will not activate unless it is properly seated.
3. Press the injection button. You will hear a click. Keep the pen pressed against the skin.
4. Hold for the full count. Hold the pen flat against the skin until the gray plunger is fully visible in the viewing window — typically about 10 seconds. Removing the pen too early can result in incomplete dose delivery and drug leakage.
5. Withdraw, do not rub. Gently remove the pen. Do not rub the injection site — rubbing can cause local inflammation and bruising.

After you inject

1. Dispose immediately. Drop the used pen directly into an FDA-cleared sharps container. Never recap a used needle. Never dispose of a used pen in a household trash can — the needle is an injury risk to waste handlers.
2. Document the site. Note which zone you used so you rotate correctly next week.
3. Normal injection-site reactions. Mild redness, swelling, or bruising at the injection site within the first hour are common and expected. These typically resolve within a day. If you see spreading redness, warmth, or have a fever, contact your prescriber.

Common injection mistakes to avoid

• Injecting cold from the refrigerator. The single most common cause of stinging injections. Always 30 minutes at room temperature first.
• Reusing the same spot week after week. Even if you cannot see lipohypertrophy yet, the tissue damage is accumulating. Rotate consistently from the start.
• Injecting into scar tissue or stretch marks. The FDA label explicitly prohibits this. ^[1] Drug absorption through scarred or modified tissue is unpredictable.
• Pulling the pen away too early. If you remove the pen before the gray plunger is fully visible, you may only deliver part of the dose. The drug that leaked out is lost — do not attempt to inject a replacement dose.
• Rubbing the injection site afterward. Rubbing mechanically disrupts the drug depot in the subcutaneous fat and increases bruising.
• Injecting through clothing. Only inject into clean, directly visible skin. You cannot accurately assess site condition, injection angle, or confirm plunger completion through clothing.
• Skipping the alcohol dry time. The alcohol wipe cleans the skin; if you inject while it is still wet, the alcohol enters the wound channel and increases stinging significantly.

What if you accidentally hit muscle?

An intramuscular (IM) injection of tirzepatide — where the needle goes into muscle instead of subcutaneous fat — is not a medical emergency. Tirzepatide is absorbed from both subcutaneous fat and muscle tissue; an IM injection typically produces slightly faster absorption rather than drug loss.

What you may notice: Transient increased nausea or GI discomfort in the 24–48 hours after a suspected IM injection, due to faster absorption kinetics. This is usually mild and self-resolving.

What to do:

• Do not inject a replacement dose — the drug was delivered.
• Document the incident and adjust technique going forward.
• If you use a vial-and-syringe system (common with compounded tirzepatide), switch to a 4 mm or 6 mm needle at a 90-degree angle, which is less likely to reach muscle in most patients.

When to call your prescriber: Severe pain at the injection site that does not improve within a few hours, a hard mass or nodule that persists beyond several days, spreading redness with warmth (possible infection), or any systemic symptoms (fever, chills) warrant a call to your prescriber or urgent care visit.

Pen vs vial — does the injection site matter differently?

The three FDA-approved injection sites (abdomen, thigh, upper arm) are identical for both the Zepbound auto-injector pen and for vial-and-syringe administration.

Zepbound auto-injector pen

The Zepbound single-dose pen has a fixed needle depth — it is designed so that when you press it flat against the skin, the needle enters to a predetermined subcutaneous depth appropriate for most adults. This makes site-selection less sensitive to technique variation. You do not need to adjust the angle or depth manually.

Vial-and-syringe (branded Zepbound vials or compounded tirzepatide)

Zepbound vials (the lower-cost LillyDirect option) and compounded tirzepatide from licensed 503A pharmacies are administered using a standard insulin syringe. With a syringe, you have more control over angle and depth:

• Needle length: 4 mm to 8 mm, depending on your prescriber's or pharmacist's recommendation based on your body composition. A 4 mm needle at 90 degrees is subcutaneous in virtually all adults. Longer needles at 90 degrees increase IM risk in leaner patients.
• Angle: 90 degrees for most patients. 45 degrees if you are lean and your prescriber recommends it.
• Dose volume: Compounded tirzepatide typically comes at higher concentrations than commercial Zepbound vials, so the injected volume is often small (0.1–0.3 mL). Volume differences do not change site selection.

Compounded tirzepatide caveat: If you are using a compounded version of tirzepatide, the injection technique instructions from your compounding pharmacy should align with the Zepbound FDA label on site selection. However, dose concentrations, volumes, and added excipients (e.g., B12 or other additives some compounders include) can vary. Follow your compounder's and prescriber's specific technique instructions alongside the general FDA-label guidance above.

Frequently asked questions

Where do you inject tirzepatide?

Tirzepatide (Zepbound and Mounjaro) is injected subcutaneously — just under the skin — at one of three FDA-label-approved sites: the abdomen, the front of the thigh, or the back of the upper arm. The verbatim Zepbound prescribing information states: 'Inject subcutaneously in the abdomen, thigh, or upper arm.' The upper-arm site is generally not recommended for self-injection because it is difficult to reach and stabilize without assistance.

What is the best site to inject tirzepatide for weight loss?

All three FDA-approved sites (abdomen, thigh, upper arm) deliver the drug to the same subcutaneous fat layer, and the FDA label does not designate any site as producing superior weight loss. In general subcutaneous pharmacokinetics, abdominal injection tends to have the fastest and most consistent absorption. The thigh is typically the easiest site for self-injection because it is easily accessible and visual. The upper arm has the least subcutaneous fat in lean patients and is harder to self-inject — assistance from another person is recommended per the FDA label.

Does it matter which injection site I use?

The site does not change the drug's weight-loss effectiveness in any clinically meaningful way. What matters more is rotating sites correctly to avoid lipohypertrophy (lumpy scar tissue under the skin from repeated injections at the exact same spot). The Zepbound FDA label states: 'Avoid injecting ZEPBOUND into the same injection site within the same week.' The thigh or abdomen is the most practical choice for most self-injecting patients.

How do I rotate injection sites for tirzepatide?

Rotate within and between the three approved sites. Each weekly injection should be at least 1 inch (roughly 2.5 cm) away from the previous injection point at that site, and you should not use the exact same spot in consecutive weeks. The Zepbound label requires avoiding areas that are 'tender, bruised, red, scaly, or hard' and areas with 'scars or stretch marks.' A common practical rotation: abdomen left side week 1, abdomen right side week 2, right thigh week 3, left thigh week 4 — then repeat.

Can I inject tirzepatide in my arm myself?

Technically yes — the upper arm is an FDA-approved injection site — but the Zepbound prescribing information specifies that upper-arm injections 'should be given by another person.' The back of the upper arm is difficult to stabilize, pinch (though the label says do not pinch), and see clearly during self-injection, which increases the risk of an intramuscular injection or an inconsistent injection depth. For true solo self-injection, the abdomen or thigh are safer and more practical.

Why does my tirzepatide injection hurt?

The most common reasons for injection pain are: (1) injecting medication that is still cold from the refrigerator — always let the pen or vial warm to room temperature for 30 minutes before injecting; (2) injecting into an area that is bruised, inflamed, or has lipohypertrophy from repeated same-site injections; (3) injecting too quickly — the Zepbound pen should be held firmly against the skin for the full injection cycle until the gray plunger is visible; (4) alcohol on the skin not allowed to dry fully before injecting. If pain is severe, persistent, or accompanied by redness and warmth, contact your prescriber.

What if I accidentally inject tirzepatide into muscle (IM)?

An accidental intramuscular injection of tirzepatide is not a medical emergency. The drug will still be absorbed — typically faster than subcutaneous absorption, which can occasionally intensify nausea transiently. The dose is not lost. Do not inject a replacement dose. If you experience unusual or severe pain at the injection site, redness spreading beyond the injection point, or systemic symptoms beyond typical GI effects, contact your prescriber or seek care. Going forward, use a shorter needle if using a vial-and-syringe system, and avoid pinching skin too deeply, which can pull muscle into the injection field.

How deep should the tirzepatide needle go?

Tirzepatide is a subcutaneous injection — the needle should enter the fat layer just below the skin, not muscle. The Zepbound auto-injector pen (single-dose) has a fixed-depth needle that handles this automatically when the pen is held flat against the skin. For vial-and-syringe administration, a 4 mm or 6 mm needle at a 90-degree angle is typically sufficient for most patients with adequate subcutaneous fat. Lean patients may need to inject at a 45-degree angle or use a 4 mm needle to stay subcutaneous. Your prescriber or pharmacist can advise on the correct needle gauge and length for your body composition.

Related research and tools

• GLP-1 shot beginner guide — what GLP-1 shots are, which brands count (Wegovy, Zepbound, Saxenda), how the mechanism works, and how much they cost
• Foundayo vs Wegovy vs Zepbound full comparison — efficacy, cost, side effects, and the oral vs injectable decision
• Wegovy alternatives 2026 — what to try when Wegovy is unavailable, unaffordable, or insufficient
• Zepbound pen dose & administration chart — all 4 pen colors, titration schedule, storage requirements
• GLP-1 titration planner — map your dose-escalation schedule by calendar week
• GLP-1 missed dose guide — what to do if you miss a weekly Zepbound or Mounjaro injection

Important disclaimer. This article summarizes the injection-site and technique instructions from the FDA-approved prescribing information for Zepbound (tirzepatide, Eli Lilly) and Mounjaro (tirzepatide, Eli Lilly). It does not constitute medical advice and does not replace individualized instruction from your prescriber or pharmacist. If your prescriber or pharmacy gave you site-specific, technique-specific, or dose-specific instructions that differ from this general summary, follow those instructions. If you experience an adverse reaction at an injection site — including pain, swelling, redness, or a mass that does not resolve within a few days — contact your prescriber. Weight Loss Rankings does not provide medical advice, diagnosis, or treatment.